Pitt Enzyme Discovery May Lead To Better Tests For Tuberculosis

Main Category: Tuberculosis
Article Date: 09 Jan 2013 - 0:00 PST

Current ratings for:
Pitt Enzyme Discovery May Lead To Better Tests For Tuberculosis

Patient / Public:not yet rated

Healthcare Prof:not yet rated


Researchers at the University of Pittsburgh Graduate School of Public Health have identified an enzyme that will trigger the rapid breakdown of several mycobacteria species, including the bacteria known to cause tuberculosis. This discovery could lead to better tests for the deadly disease. The results of the study, funded by the National Institutes of Health (NIH), are published in the January edition of the Journal of Biological Chemistry.

Tuberculosis is one of the most deadly global bacterial infections, killing more than 2 million people worldwide annually. Doctors see 9 million new cases of the disease every year, mostly in Africa and Southeast Asian countries, although small outbreaks of the disease have been reported in urban areas of the United States. Tuberculosis is caused by bacteria called Mycobacterium tuberculosis. The TB bacteria usually attack the lungs and are spread through the air from one person to another.

"It's a huge public health burden," said Anil Ojha, Ph.D., assistant professor in the Department of Infectious Diseases and Microbiology at Pitt Public Health, and senior author of the study. "Clearly, controlling the infection is heavily dependent upon an effective diagnosis."

The current bacterial culture test for TB infections is highly accurate but time-consuming, taking up to several weeks.

"That may create a race against time for a patient who has acute tuberculosis infection," said Dr. Ojha. "That's why our process is so important. It can obtain results that are both rapid and accurate."

The World Health Organization (WHO) currently recommends a diagnostic technique called nucleic acid-based amplification (NAA); however, this process faces difficulty in breaking open, or lysing bacteria, to access nucleic acids. Mycobacteria are shaped by a thick envelope of fats and sugars, and are resistant to most of the chemicals conventionally used to lyse bacteria.

Pitt Public Health researchers found that exposure to an esterase, an enzyme that targets fatty acids on the surface of the mycobacterial envelope, led to rapid lysis of the bacilli. Researchers also demonstrated that this quick lysis of Mycobacterium tuberculosis improved its detection at lower density.

"Discovery of enzyme-based mycobacteria lysis has the potential to increase the sensitivity of NAA," said Dr. Ojha.

Collaborators on this study include: Yong Yang, Ph.D., Alexandra Bhatti, M.P.H., Danxia Ke, and Peijun Zhang, Ph.D., all of the University of Pittsburgh; Mercedes Gonzalez-Juarrero, Ph.D., and Anne Lenaerts, Ph.D., both of Colorado State University; Laurent Kremer, Ph.D., of the University of Montpellier; and Yann Guerardel, of the French National Center for Scientific Research.

The research was funded by NIH grants AI079288 and GM085043.

Article adapted by Medical News Today from original press release. Click 'references' tab above for source.
Visit our tuberculosis section for the latest news on this subject.
Source: University of Pittsburgh Graduate School of Public Health
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
University of Pittsburgh. "Pitt Enzyme Discovery May Lead To Better Tests For Tuberculosis." Medical News Today. MediLexicon, Intl., 9 Jan. 2013. Web.
24 May. 2013. <http://www.medicalnewstoday.com/releases/254699.php>

APA
University of Pittsburgh. (2013, January 9). "Pitt Enzyme Discovery May Lead To Better Tests For Tuberculosis." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/254699.php.

Please note: If no author information is provided, the source is cited instead.



Add Your Opinion On This Article

'Pitt Enzyme Discovery May Lead To Better Tests For Tuberculosis'

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Your Name:*
E-mail Address:*
Your Opinion Title:*
Opinion:*
This is to help prevent SPAM submissions. Please enter the words exactly as they appear, including capital letters and punctuation.*

* Fields marked with a * need to be filled in before you hit the submit button.

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.


Tuberculosis

What Is Tuberculosis?

Tuberculosis (TB) is an infectious disease that is caused by a bacterium called Mycobacterium tuberculosis. TB primarily affects the lungs, but it can also affect organs in the central nervous system, lymphatic system, and circulatory system among others. Read more...

Most Popular Articles



Follow Our Tuberculosis News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Tuberculosis Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »